Literature DB >> 29243290

A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family.

Whitney Besse1, Jungmin Choi2, Dina Ahram3, Shrikant Mane2, Simone Sanna-Cherchi3, Vicente Torres4, Stefan Somlo1,2.   

Abstract

Expanded mutation detection and novel gene discovery for isolated polycystic liver disease (PCLD) are necessary as 50% of cases do not have identified mutations in the seven published disease genes. We investigated a family with five affected siblings for which no loss-of-function variants were identified by whole exome sequencing analysis. SNP genotyping and linkage analysis narrowed the candidate regions to ∼8% of the genome, which included two published PCLD genes in close proximity to each other, GANAB and LRP5. Based on these findings, we re-evaluated the exome sequencing data and identified a novel intronic nine base pair deletion in the vicinity of the GANAB exon 24 splice donor that had initially been discarded by the sequence analysis pipelines. We used a minigene assay to show that this deletion leads to skipping of exon 24 in cell lines and primary human cholangiocytes. These findings prompt genomic evaluation beyond the coding region to enhance mutation detection in PCLD and to avoid premature implication of other genes in linkage disequilibrium.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GANAB; LRP5; minigene; polycystic liver disease; splice assay

Mesh:

Substances:

Year:  2018        PMID: 29243290      PMCID: PMC5805583          DOI: 10.1002/humu.23383

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  25 in total

1.  Use of minigene systems to dissect alternative splicing elements.

Authors:  Thomas A Cooper
Journal:  Methods       Date:  2005-12       Impact factor: 3.608

2.  Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.

Authors:  Esmé Waanders; René H M te Morsche; Rob A de Man; Jan B M J Jansen; Joost P H Drenth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

3.  Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.

Authors:  D M Reynolds; C T Falk; A Li; B F King; P S Kamath; J Huston; C Shub; D M Iglesias; R S Martin; Y Pirson; V E Torres; S Somlo
Journal:  Am J Hum Genet       Date:  2000-10-23       Impact factor: 11.025

4.  Isolated polycystic liver disease genes define effectors of polycystin-1 function.

Authors:  Whitney Besse; Ke Dong; Jungmin Choi; Sohan Punia; Sorin V Fedeles; Murim Choi; Anna-Rachel Gallagher; Emily B Huang; Ashima Gulati; James Knight; Shrikant Mane; Esa Tahvanainen; Pia Tahvanainen; Simone Sanna-Cherchi; Richard P Lifton; Terry Watnick; York P Pei; Vicente E Torres; Stefan Somlo
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

5.  Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing.

Authors:  Michael Krawczak; Nick S T Thomas; Bernd Hundrieser; Matthew Mort; Michael Wittig; Jochen Hampe; David N Cooper
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

6.  Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.

Authors:  Joost P H Drenth; Rene H M te Morsche; Renate Smink; Juan S Bonifacino; Jan B M J Jansen
Journal:  Nat Genet       Date:  2003-02-10       Impact factor: 38.330

Review 7.  Polycystin-1: a master regulator of intersecting cystic pathways.

Authors:  Sorin V Fedeles; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Trends Mol Med       Date:  2014-01-31       Impact factor: 11.951

8.  Clinical profile of autosomal dominant polycystic liver disease.

Authors:  Qi Qian; Airong Li; Bernard F King; Patrick S Kamath; Donna J Lager; John Huston; Clarence Shub; Sonia Davila; Stefan Somlo; Vicente E Torres
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  UniProt: the universal protein knowledgebase.

Authors: 
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

View more
  9 in total

1.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

Review 2.  Next-Generation Sequencing-Based Genetic Diagnostic Strategies of Inherited Kidney Diseases.

Authors:  Jiahui Zhang; Changming Zhang; Erzhi Gao; Qing Zhou
Journal:  Kidney Dis (Basel)       Date:  2021-09-29

Review 3.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

Review 4.  Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.

Authors:  Paula Olaizola; Pedro M Rodrigues; Francisco J Caballero-Camino; Laura Izquierdo-Sanchez; Patricia Aspichueta; Luis Bujanda; Nicholas F Larusso; Joost P H Drenth; Maria J Perugorria; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-13       Impact factor: 73.082

5.  Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.

Authors:  Sarah R Senum; Ying Sabrina M Li; Katherine A Benson; Giancarlo Joli; Eric Olinger; Sravanthi Lavu; Charles D Madsen; Adriana V Gregory; Ruxandra Neatu; Timothy L Kline; Marie-Pierre Audrézet; Patricia Outeda; Cherie B Nau; Esther Meijer; Hamad Ali; Theodore I Steinman; Michal Mrug; Paul J Phelan; Terry J Watnick; Dorien J M Peters; Albert C M Ong; Peter J Conlon; Ronald D Perrone; Emilie Cornec-Le Gall; Marie C Hogan; Vicente E Torres; John A Sayer; Peter C Harris
Journal:  Am J Hum Genet       Date:  2021-12-09       Impact factor: 11.043

6.  Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county.

Authors:  Tatsuya Suwabe; Alanna M Chamberlain; Jill M Killian; Bernard F King; Adriana V Gregory; Charles D Madsen; Xiaofang Wang; Timothy L Kline; Fouad T Chebib; Marie C Hogan; Patrick S Kamath; Peter C Harris; Vicente E Torres
Journal:  JHEP Rep       Date:  2020-08-04

Review 7.  Molecular Mechanisms of Isolated Polycystic Liver Diseases.

Authors:  Ziqi Yu; Xiang Shen; Chong Hu; Jun Zeng; Aiyao Wang; Jianyong Chen
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

Review 8.  Polycystic Liver Disease: Advances in Understanding and Treatment.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Annu Rev Pathol       Date:  2021-11-01       Impact factor: 23.472

9.  Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.

Authors:  Ramón Peces; Rocío Mena; Yolanda Martín; Concepción Hernández; Carlos Peces; Dolores Tellería; Emilio Cuesta; Rafael Selgas; Pablo Lapunzina; Julián Nevado
Journal:  Mol Genet Genomic Med       Date:  2020-06-13       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.